Target intelligence / Profile preview

Adenylate kinase (AK)

Target
AK
Molecular classification
Enzyme, Phosphotransferase
01

Overview

Adenylate kinase is a highly conserved phosphotransferase enzyme (EC 2.7.4.3) present in all known organisms and tissues[2][3][8]. It catalyzes the reversible transfer of phosphate groups among adenine nucleotides, specifically the interconversion of ATP, ADP, and AMP (2 ADP ⇌ ATP + AMP), which is critical for maintaining cellular energy balance[1][3][8][10]. The enzyme consists of distinct domains for binding nucleotides and undergoes significant conformational changes during catalysis[1][5]. Multiple isoforms are found in humans, with tissue- and compartment-specific functions[2]. Adenylate kinase is involved in regulating nucleotide pools, supports various cellular signaling pathways, interacts with other metabolic enzymes and protein complexes, and impacts physiological processes such as cell maturation, apoptosis, and response to metabolic stress[2][3][9]. Its dysfunction has been linked to cardiovascular disease, cancer, and certain genetic disorders, supporting its emerging role as a therapeutic target and a marker for disease diagnosis or prognosis[2][9].

Other names
ADKmyokinaseATP-AMP phosphotransferaseEC 2.7.4.3Nucleoside monophosphate kinaseAdenylkinase
02

Mechanism of action

Inhibition of adenylate kinase activity blocks the conversion/interconversion of AMP, ADP, and ATP, thereby disrupting nucleotide balance and cellular energy charge[8][9].

03

Biological functions

Cellular energy metabolismNucleotide homeostasisSignal transductionRegulation of cell differentiationApoptosisOncogenesisCell proliferation
04

Disease associations

CancerCardiovascular disease (e.g., ischemia, myocardial injury)Hemolytic anemiaAleukocytosisPrimary ciliary dyskinesiaMetabolic disorders
05

Safety considerations

Essential for basic energy homeostasis, so inhibition leads to widespread bioenergetic disruption and potentially cytotoxicity.Non-isoform-selective targeting risks affecting multiple tissues and cell types.
06

Interacting drugs

Ap5A (P^1^,P^5^-di(adenosine-5') pentaphosphate, an inhibitor used experimentally)[4][5]

1 more in the full profile.

07

Biomarkers

Adenylate kinase isoenzyme levels may serve as biomarkers in diseases such as myocardial infarction, certain hemolytic anemias, and metabolic stress[2][9].

Beyond the preview

Go deeper on Adenylate kinase (AK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenylate kinase (AK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call